We think that patients that were treated for a T2 glottic carcinoma with radiotherapy have mild-to moderate dysphonic voices, no problems with swallowing and a good quality of life.
ID
Bron
Verkorte titel
Aandoening
Early glottic cancer, T2 glottic carcinoma, voice outcome, radiotherapy, radiation therapy, voice quality, voice function, quality of life
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Voice outcome<br>
Voice quality (Voice Handicap Index questionnaire)<br>
Voice function (maximum phonation time, fundamental frequency, dynamic range and perceptual evaluation)
Achtergrond van het onderzoek
Introduction: Several studies report functional outcomes (voice function, voice quality, quality of life, and swallowing function) after treatment with radiotherapy for T1 glottic carcinoma. Patients with T1 glottic tumors show the same results, regarding the functional outcomes, after radiotherapy of transoral laser microsurgery (TLM). However, for patients with T2 tumors treated with radiotherapy, these results are not frequently decribed. Due to the lack of these data, we would like to perform a study to investigate the long-term functional outcomes of patienst treated with radiotherapy. The objective of this study is to determine the functional outcomes (voice function, voice quality, quality of life and swallowing function) in patients who were treated with radiotherapy for a T2 glottic tumor between 2008 and 2016.
Method: a crossectionals study will be performed, where patients will be asked to fill in two questionnaaires. Furthermore, voice analysis will be performed in the outpatient clinics.
Doel van het onderzoek
We think that patients that were treated for a T2 glottic carcinoma with radiotherapy have mild-to moderate dysphonic voices, no problems with swallowing and a good quality of life.
Onderzoeksopzet
1 time
Onderzoeksproduct en/of interventie
Questionnaires and recordings from the speech
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients treated with RT between 2008 and 2016 because of a T2 glottic carcinoma
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Patients with recurrent disease
Patients that are not able to read or speak Dutch
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL7480 |
| NTR-old | NTR7722 |
| CCMO | NL66191.058.18 |
| OMON | NL-OMON45759 |